Get started
Author

Martin Chase Marak

Observed name: Martin C. Marak
ORCID: 0009-0008-0908-7911
Observed ORCID: 0009-0008-0908-7911
OpenAlex ID: A5000431306
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6–17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
2022 · Laurel H. Messer, Bruce A. Buckingham, et al. · Diabetes Technology & Therapeutics · 58
A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes
2022 · Davida Kruger, Alex Kass, et al. · Diabetes Technology & Therapeutics · 38
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
2024 · Irl B. Hirsch, Roy W. Beck, et al. · Diabetes Care · 32
PDF
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes
2024 · Irl B. Hirsch, Roy W. Beck, et al. · Diabetes Care · 26
PDF
An evaluation of how exercise position statement guidelines are being used in the real world in type 1 diabetes: Findings from the type 1 diabetes exercise initiative (T1DEXI)
2024 · Peter G. Jacobs, Martin Chase Marak, et al. · Diabetes Research and Clinical Practice · 20
PDF
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort
2024 · Lauren V. Turner, Martin Chase Marak, et al. · Diabetologia · 14
PDF
Testing the Real-World Accuracy of the Dexcom G6 Pro CGM During the Insulin-Only Bionic Pancreas Pivotal Trial
2023 · Martin Chase Marak, Peter Calhoun, et al. · Diabetes Technology & Therapeutics · 11
PDF
A Randomized Controlled, Double-Masked, Crossover Study of a GPR119 Agonist on Glucagon Counterregulation During Hypoglycemia in Type 1 Diabetes
2025 · Anika Bilal, Anna Casu, et al. · Diabetes · 6
The Association Between Diet Quality and Glycemic Outcomes Among People with Type 1 Diabetes
2024 · Melanie B Gillingham, Martin Chase Marak, et al. · Current Developments in Nutrition · 5
An overview of reviews and synthesis across 440 studies examines the importance of hospital readmission predictors across various patient populations
2023 · Janina J. Koch, Patrick E. Beeler, et al. · Journal of Clinical Epidemiology · 4
PDF
Colpocleisis—Still a Valuable Option: A Point of Technique
2025 · Diana Hoehn, Hannes Egli, et al. · Journal of Clinical Medicine
PDF
A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
2025 · Anika Bilal, Anna Casu, et al.
A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
2025 · Anika Bilal, Anna Casu, et al.
A Randomized Comparison of Post-prandial Glucose Excursion Using Inhaled Insulin Versus Rapid-acting Analogue Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
2024 · Irl B. Hirsch, Roy W. Beck, et al.
PDF
A Randomized Comparison of Post-prandial Glucose Excursion Using Inhaled Insulin Versus Rapid-acting Analogue Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery
2024 · Irl B. Hirsch, Roy W. Beck, et al.
Utility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study
2023 · Nelly Mauras, Edward R. Damiano, et al. · Diabetes Technology & Therapeutics
PDF
Works count: 17
Citation count: 238
H-index: 8
I10-index: 8
Year
Topic
Type